NCT02321618 is a NA clinical trial of BP measurement & pharmacy in Hypertension, sponsored by Cedars-Sinai Medical Center.

Who is sponsoring NCT02321618?

NCT02321618 is sponsored by Cedars-Sinai Medical Center.

What drugs are being tested in NCT02321618?

Interventions in NCT02321618: BP measurement & pharmacy, BP educational materials.

What condition does NCT02321618 study?

NCT02321618 studies Hypertension.

Is NCT02321618 still recruiting?

NCT02321618 is currently completed. Last updated 10 July 2018.

Last reviewed 2018-07-10 · How we verify

NCT02321618

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cut Your Pressure Too: The Los Angeles Barbershop Blood Pressure Study

Completed NA Last updated 10 July 2018

What this trial tests

NA trial testing BP measurement & pharmacy in Hypertension in 320 participants. Completed in 9 January 2018.

Timeline

17 February 2015

Primary endpoint
30 June 2017

9 January 2018

Quick facts

Lead sponsor	Cedars-Sinai Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	320
Start date	17 February 2015
Primary completion	30 June 2017
Estimated completion	9 January 2018
Sites	1 location across United States

Drugs / interventions tested

BP measurement & pharmacy
BP educational materials

Conditions studied

Hypertension — all drugs for Hypertension →

Sponsor

Cedars-Sinai Medical Center

Who can join

Adults 35 to 79, male only, with Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

African-American men suffer more than most other groups from hypertension (HTN) but often have less access and less contact with doctors. Previous work by the study's Principal Investigator in Dallas, Texas, and Altadena, California, showed that barbershops are an excellent place to identify black men with high blood pressure and to enlist the aid of their barbers as healthcare extenders. The purpose of this study in Metro Los Angeles (LA) is to compare two types of barber-based patient-centered blood pressure programs to see which type is more effective in improving the customers' high blood pressure. One type emphasizes blood pressure medication and the other type emphasizes lifestyle modification for high blood pressure.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops.
Victor RG, Lynch K, Li N, Blyler C, et al · · 2018 · cited 437× · PMID 29527973 · DOI 10.1056/nejmoa1717250
The association between diabetes and nocturia: A systematic review and meta-analysis.
Fu Z, Wang F, Dang X, Zhou T. · · 2022 · cited 21× · PMID 36262225 · DOI 10.3389/fpubh.2022.924488
Nocturia as an Unrecognized Symptom of Uncontrolled Hypertension in Black Men Aged 35 to 49 Years.
Victor RG, Li N, Blyler CA, Mason OR, et al · · 2019 · cited 21× · PMID 30827133 · DOI 10.1161/jaha.118.010794

Verify or expand the search:

Other recruiting trials for Hypertension

Currently open trials in the same condition.

NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting

Other Cedars-Sinai Medical Center trials

Trials by the same sponsor.

NCT06012487 — Correlates and Control of Blood Pressure Variability · Phase 1 · not yet recruiting
NCT07495995 — SAMe for Prevention of Liver Cancer in MASLD-Related Cirrhosis · Phase 2 · not yet recruiting
NCT07413965 — TAVR vs SAVR in Severe Bicuspid Aortic Stenosis · NA · not yet recruiting
NCT06521021 — CHOICE to AVOID or RESIST · NA · not yet recruiting
NCT07499089 — Together-Breast Cancer Support Platform · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02321618 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cedars-Sinai Medical Center
Last refreshed: 10 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02321618.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing